Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Q3 Earnings Spotlight: Abiomed Shines Among Cardiology Device-Makers

Executive Summary

Reported sales and earnings from the publicly traded cardiovascular device companies show strong performance across the sector, spurred by new approvals and clinical trials, in the quarter that ended Sept. 30. Here's a recap of results from the cardio device companies that have reported so far, including Abbott, Abiomed, and Reva.

Advertisement

Related Content

Abiomed Touts New Study Results, Potential To Revolutionize Heart-Attack Treatment
Focus More On Patients, Less On Hospitals, Experts Tell Device Companies
TCT 2018: Abbott Expects COAPT Results To Support Expanding MitraClip's Indication
Earnings Winners & Losers: ISHG Beats Forecasts; JNJ Ortho Sales Still Soft; ABT; DNH
Global Device Approvals Q2 Shapshot: Coronary Devices Abound
EuroPCR 2018: New Stents Show Way Forward Post-Absorb
EuroPCR 2018: Abbott's Tendyne Mitral Valve Shows Early Promise
Abbott 'No-Fingerstick' CGM System For Diabetes Wins Medicare Coverage
OUS Approvals Analysis: Small Companies Dominate International Approvals In April

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT124217

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel